Related Experiment Video
Updated: Aug 13, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Sodium orthovanadate suppresses DNA damage-induced caspase activation and apoptosis by inactivating p53
1Department of Radiological Health, Graduate School of Medicine, University of Tokyo, Tokyo 113-0033, Japan. morita@m.u-tokyo.ac.jp
Abstract:
We previously reported that p42/SETbeta is a substrate for caspase-7 in irradiated MOLT-4 cells, and that treating the cells with sodium orthovanadate (vanadate) inhibits p42/SETbeta's caspase-mediated cleavage. Here, we initially found that the inhibitory effect of vanadate was due to the suppression of caspase activation but not of caspase activity. Further investigations revealed that vanadate suppressed upstream of apoptotic events, such as the loss of mitochondrial membrane potential, the conformational change of Bax, and p53 transactivation, although the accumulation, total phosphorylation, and phosphorylation of six individual sites of p53 were not affected. Importantly, vanadate suppressed p53-dependent apoptosis, but not p53-independent apoptosis. Finally, gel-shift and chromatin immunoprecipitation assays conclusively demonstrated that vanadate inhibits the DNA-binding activity of p53. Vanadate is conventionally used as an inhibitor of protein tyrosine phosphatases (PTPs); however, we recommend that the influence of vanadate not only on PTPs but also on p53 be considered before using it.
Insights
Sodium orthovanadate (vanadate) inhibits apoptosis by suppressing caspase activation and p53 DNA-binding activity. This finding is crucial for understanding vanadate
Area of Science:
- Cellular Biology
- Biochemistry
- Molecular Biology
Background:
- p42/SETbeta is a substrate for caspase-7 in irradiated MOLT-4 cells.
- Sodium orthovanadate (vanadate) inhibits p42/SETbeta's caspase-mediated cleavage.
Purpose of the Study:
- To elucidate the mechanism by which vanadate inhibits caspase-mediated cleavage of p42/SETbeta.
- To investigate the upstream effects of vanadate on apoptotic pathways.
- To determine vanadate's impact on p53 activity and p53-dependent apoptosis.
Main Methods:
- Cell culture (MOLT-4 cells)
- Irradiation
- Sodium orthovanadate treatment
- Caspase activity assays
- Mitochondrial membrane potential assessment
- Bax conformational change analysis
- p53 transactivation assays
- Western blotting
- Gel-shift assays
- Chromatin immunoprecipitation assays
Main Results:
- Vanadate suppresses caspase activation, not caspase activity.
- Vanadate inhibits upstream apoptotic events including mitochondrial membrane potential loss, Bax conformational change, and p53 transactivation.
- Vanadate suppresses p53-dependent apoptosis but not p53-independent apoptosis.
- Vanadate inhibits the DNA-binding activity of p53.
Conclusions:
- Vanadate's inhibitory effect on p42/SETbeta cleavage is mediated by the suppression of caspase activation.
- Vanadate interferes with key apoptotic signaling pathways upstream of caspase activation.
- Vanadate specifically inhibits p53-dependent apoptosis by blocking p53 DNA-binding activity.
- The use of vanadate should consider its impact on p53 function in addition to its role as a protein tyrosine phosphatase inhibitor.
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Caspases
The Intrinsic Apoptotic Pathway
DNA Damage Can Stall the Cell Cycle

